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Interleukin-6 is increased in plasma and cerebrospinal fluid of
community-dwelling domestic dogs with acute
ischaemic stroke
Hanne Gredala, Barbara B. Thomsena, Antonio Boza-Serranof, Laurent Garosig,
Clare Rusbridgeh, Daniel Anthonyi, Arne Møllerb, Bente Finsenc,
Tomas Deierborgf, Kate L. Lambertsenc,d,e,* and Mette Berendta,*
Inflammatory cytokines are potential modulators of infarct
progression in acute ischaemic stroke, and are therefore
possible targets for future treatment strategies. Cytokine
studies in animal models of surgically induced stroke may,
however, be influenced by the fact that the surgical
intervention itself contributes towards the cytokine
response. Community-dwelling domestic dogs suffer from
spontaneous ischaemic stroke, and therefore, offer the
opportunity to study the cytokine response in a noninvasive
set-up. The aims of this study were to investigate cytokine
concentrations in plasma and cerebrospinal fluid (CSF) in
dogs with acute ischaemic stroke and to search for
correlations between infarct volume and cytokine
concentrations. Blood and CSF were collected from dogs
less than 72 h after a spontaneous ischaemic stroke. Infarct
volumes were estimated on MRIs. Interleukin (IL)-2, IL-6, IL-
8, IL-10 and tumour necrosis factor in the plasma, CSF and
brain homogenates were measured using a canine-specific
multiplex immunoassay. IL-6 was significantly increased in
plasma (P= 0.04) and CSF (P= 0.04) in stroke dogs
compared with healthy controls. The concentrations of other
cytokines, such as tumour necrosis factor and IL-2, were
unchanged. Plasma IL-8 levels correlated significantly with
infarct volume (Spearman’s r= 0.8, P= 0.013). The findings
showed increased concentrations of IL-6 in the plasma and
CSF of dogs with acute ischaemic stroke comparable to
humans. We believe that dogs with spontaneous stroke
offer a unique, noninvasive means of studying the
inflammatory processes that accompany stroke while
reducing confounds that are unavoidable in experimental
models. NeuroReport 28:134–140 Copyright © 2017 The
Author(s). Published by Wolters Kluwer Health, Inc.
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Introduction
Adverse inflammatory reactions have been shown to play
key roles in the progressive pathology and loss of neuro-
logical function in acute ischaemic stroke [1].
Inflammatory cytokines, in particular interleukin (IL)-1β,
IL-6, IL-10 and tumour necrosis factor (TNF), are
potential modulators of infarct progression [2,3].
Accordingly, these cytokines may represent possible
targets for future neuroprotective strategies.
Several experimental studies have sought to clarify the
inflammatory roles of these cytokines after stroke. It is
clear that IL-1β can play both a neurotoxic and a proin-
flammatory role [4,5], whereas IL-10 is believed to
behave primarily as an anti-inflammatory neuroprotective
cytokine [6]. For IL-6 and TNF, the effect of elevated
expression is less straightforward as these cytokines seem
to possess both neurotoxic and neuroprotective proper-
ties [3,7,8]. IL-2, although usually not considered a main
player in ischaemic stroke, seems to contribute towards
the adverse inflammatory reactions [9].
To date, experimental rodent models of ischaemic stroke
have highlighted a role for mediators of inflammation in
acute ischaemic stroke [10]. However, the translation of
otherwise encouraging results from animal models into
humans has been disappointing [11]. Apart from early
(< 4.5 h) intravenous administration of recombinant tis-
sue plasminogen activators, treatment strategies have
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failed to prevent progressive cell death of the peri-infarct
area in humans [12]. Even though rodent models have
been developed that enable control of the size of the
cerebral injury and provide an opportunity to study
mechanistic pathways, they often fail to reproduce the
heterogeneity of human stroke patients, where disease is
multifactorial and infarcts of various sizes appear at dif-
ferent sites [10]. With respect to studies of inflammatory
reactions in animal models of surgically induced stroke,
interpretation of results is further complicated by the fact
that the surgical intervention contributes towards the
inflammatory response [13].
Although less common than in humans, domestic dogs
also suffer from naturally occurring ischaemic stroke [14,15].
Affected dogs are presented at veterinary hospitals where
the presentation of acute neurological signs and MRI
findings resemble those in humans [14,15]. As the anat-
omy of dogs also shares many similarities with humans in
respect to the gyrencephalic brain, grey–white matter
composition and circle of Willis [16,17], dogs with stroke
could provide a highly translatable noninvasive clinical
model for early infarct development. Supposedly,
inflammatory mechanisms in canine ischaemic stroke are
also comparable to humans, which would further support
the use of this model. However, poststroke inflammation
including the expression of cytokines with acute ischae-
mic stroke has only been subject to limited investigation
in dogs [18].
In the present study, we investigated the poststroke
concentrations of the cytokines IL-2, IL-6, IL-8, IL-10
and TNF in plasma and cerebrospinal fluid (CSF) in
community-dwelling domestic dogs with spontaneous
ischaemic stroke compared with healthy control dogs.
The aim of this study was to investigate the inflammatory
cytokine response after spontaneous stroke in dogs as a
potential model for early inflammatory mechanisms in
ischaemic stroke.
Methods
Animals
Nine community-dwelling domestic dogs of various
breeds presenting with acute neurological signs (< 72 h)
and a MRI diagnosis of ischaemic stroke were investi-
gated in this prospective multicentre study including
three veterinary referral hospitals [median age: 9 years;
interquartile range (IQR)= 5.5–11.5] (Table 1).
Control blood samples were collected at the University
Hospital for Companion Animals (UHCA), Copenhagen
University, Denmark, from nine healthy dogs (five
females and four males) with a median age of
5 years (IQR= 2.5–8.5); dogs of various breeds (three
Greyhounds, two Labrador retrievers, two Dachshunds,
one Whippet and one Italian Greyhound) were enroled
as controls at the UHCA. Control CSF samples
were collected from three healthy large mixed breeds
(two females, one male; median age: 5 years; IQR=
3–12 years) that were euthanized at the UHCA at the
owners’ request with no apparent neurological or sys-
temic conditions.
The study was approved by the Local Administrative and
Ethics Committee, Department of Veterinary Clinical
and Animal Sciences, Faculty of Health and Medical
Sciences, University of Copenhagen (permission num-
ber: 1N/2013), and all procedures were completed with
the owners’ consent.
Magnetic resonance imaging
MRIs were performed under general anaesthesia [pre-
medication with methadone (0.2–0.3 mg/kg) intra-
muscularly or dexdomitor (41 mcg/m2) and butorphanol
(0.1 mg/kg) intravenously, induction of anaesthesia with
diazepam (0.2–0.3 mg/kg) intravenously, followed by
propofol intravenous dosed to allow endotracheal intu-
bation and anaesthesia maintained by isoflurane in oxy-
gen administered by inhalation]. The following MRI
equipment was used: 0.2 T (Esaote Vet MR; Esaote,
Genoa, Italy) at the UHCA, 0.4 T (Aperto Permanent
Magnet; Hitachi, Tokyo, Japan) at Davies Veterinary
Specialists and 1.5 T MRI (Siemens Symphony,
Erlangen, Germany) at Fitzpatrick’s Referrals, UK. MRI
included T1- and T2-weighted images, transverse and
sagittal sections and contrast images, and fluid-attenuated
inversion recovery. Gadolinium dimeglumine (Magnevist;
Schering Diagnostics AG, Berlin, Germany), gadoteridol
(Prohance; Bracco Imaging, Cranberry, New Jersey,
USA) or gadoteric acid (Dotarem; Guerbet, Villepinte,
France) at a dose of 0.1 mmol/kg intravenously were used
as the paramagnetic contrast media.
Infarct volumetric estimations
A transparent uniform point grid was placed on the
T2-weighted image transverse section images. Grid
points associated with the infarct were counted for each
slice, defining the region of interest (ROI). Infarct
volumes were estimated using the Cavalieri theorem
Vtotal ¼ ta pð ÞSP, where V is the total volume of the
infarct, t is the average thickness between slices, a pð Þ is
the area per point and SP is the total number of points
within the ROI [19]. Area ½a pð Þ was adjusted between
infarcts to optimize volume estimations by adjusting
for differences in whole brain and infarct size (median:
12.4; minimum= 6.76; maximum= 44.89 mm2). Infarct
volumes were additionally assessed by manual perimeter
tracing on each MRI slice and ROI segmentation with
total volume estimation available using OsiriX Lite 6.5
(Pixmeo, Geneva, Switzerland). All volumetric estimates
were carried out by a single rater, who was blinded to the
patient data and cytokine results.
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Collection of blood and cerebrospinal fluid
All sample material was collected within 72 h of stroke
onset (Table 1). Blood sampling from dogs with ischae-
mic stroke was performed by jugular or cephalic venous
puncture using a BD vacutainer system (BD, Franklin,
New Jersey, USA) connected to a 21 G butterfly catheter.
Blood was collected into EDTA, serum and citrate-
stabilized vacutainerCSF was collected into EDTA
tubes from animals under general anaesthesia by atlanto-
occipital puncture in relation to the MRI procedure.
All samples were fast frozen and stored at − 80°C until
further processing.
Cytokine measurements
Cytokine protein concentrations were determined in
plasma and CSF (25 µl/sample) using a commercially
available canine-specific multiplex immunoassay using
electrochemiluminescence detection technology [MSD
Canine Proinflammatory Panel 3 Ultra-Sensitive Kit (IL-
2, IL-6, IL-8, TNF) and Canine IL-10 Ultra-Sensitive
Kit (Mesoscale Discovery, Rockville, Maryland, USA)]
and a SECTOR Imager 6000 (Mesoscale Discovery)
Plate Reader according to the manufacturer’s recom-
mendations. Samples were diluted two-fold in Diluent 41
and analysed in duplex; the average value was used for
statistical analyses. All samples were run at the same time
at a single central laboratory.
Statistical analysis
Data were analysed using GraphPad Prism 6 (GraphPad
Software Inc., La Jolla, California, USA). The
Mann–Whitney U-test for nonparametric data was used
for the comparison of medians between groups. Results
are given as median values with IQR. Possible correla-
tions between blood and CSF cytokine concentrations
and correlations between infarct volumes and blood and
CSF cytokine concentrations, respectively, were ana-
lysed by Spearman’s rank correlation analysis for non-
parametric data. P values less than or equal to 0.05 were
considered statistically significant.
Results
Clinical presentation
Nine dogs were identified with acute neurological signs,
including altered mentation, postural deficits, ataxia,
cranial nerve deficits and/or vestibular signs depending
on the site of the lesion (Table 1). Confirmatory MRI
studies were carried out within 72 h of the clinical onset.
Infarcts were located on the middle cerebral artery ter-
ritory (n= 2), the thalamus (n= 1), the caudate nucleus
(n= 1) or the rostral cerebellar artery corresponding to the
superior cerebellar artery in humans (Fig. 1 and Table 1).
Eight dogs recovered after stroke, whereas one dog
was euthanized on day 3 at the owners’ request
(Table 1, ID 1).
Infarct volumetric estimations
Infarct volumes were estimated on MRIs using the
Cavalieri theorem applied to the ROIs [19] and with total
volume estimation following manual tracing in OsiriX
Lite 6.5 (Pixmeo), respectively. Infarct volumes esti-
mated by these two methods were closely correlated
(r= 0.98, P= 0.0004) (Spearman’s rank correlation ana-
lysis). The largest infarcts were associated with total
middle cerebral artery occlusions yielding volume esti-
mates (OsiriX) of 4.017 and 5.161 mm3, ID 1 and ID 5,
respectively (Table 1).
Measurement of cytokine concentrations
Plasma levels of IL-6 were significantly higher in dogs
with stroke (median: 6.12; IQR= 2.96–18.7) than in
controls (median: 2.66; IQR= 1.14–5.3) (P= 0.04)
(Fig. 2a). Similar results were observed in CSF samples;
the median IL-6 concentration in stroke dogs was 5.74
(IQR= 1.88–7.75) as opposed to 0.69 in controls
(IQR= 0.04–0.93) (P= 0.04) (Fig. 2f). The median con-
centrations of IL-2, IL-8, IL-10 and TNF did not differ
significantly between groups in either plasma or CSF
samples (Fig. 2) (Mann–Whitney U-test).
Correlation analyses of cytokines in plasma and
cerebrospinal fluid
Cytokine concentrations in plasma did not correlate with
those in CSF (IL-2 CSF vs. plasma: Spearman’s r=− 0.1,
P= 0.95; IL-6 CSF vs. plasma: Spearman’s r=− 0.5, P=
0.45; IL-8 CSF vs. plasma: Spearman’s r= 0.37, P= 0.5;
IL-10 CSF vs. plasma: Spearman’s r= 0.9, P= 0.08; TNF
CSF vs. plasma: Spearman’s r=− 0.14, P= 0.8).
Correlations of cytokines with infarct volume
Only plasma IL-8 correlated significantly with infarct size
as estimated by total volume estimation in OsiriX Lite
6.5 (Spearman’s r= 0.8, P= 0.013). No other statistically
significant correlations were found between infarct
volume and cytokine concentrations in plasma or CSF
(data not shown).
Discussion
The main focus of the present study was to investigate
infarct size and the presence and levels of cytokines IL-2,
IL-6, IL-8, IL-10 and TNF in plasma, CSF and brain
tissue of community-dwelling domestic dogs within 72 h
of spontaneous ischaemic stroke as a possible model of
human stroke.
We found that IL-6 was significantly higher in dogs with
acute ischaemic stroke of various sizes and locations, in
both plasma and CSF, compared with healthy control
dogs. This finding is in agreement with several studies of
serum and CSF concentrations of cytokines within 72 h
of human ischaemic stroke (< 72 h) [20–24]. Clinical
studies in humans have shown a rapid increase in serum
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IL-6 within hours of stroke onset, reaching a plateau
around day 3 and then subsiding to reach baseline levels
by day 7 [22,24]. This would support that the temporal
profile of IL-6 after stroke in humans and dogs is com-
parable. In accordance with clinical studies, experimental
studies of the temporal profile of IL-6 in rodents report
elevated IL-6 mRNA from 3 to 72 h, with peak expres-
sions between 10 and 18 h [25].
IL-6 in humans in both serum and CSF has previously
been shown to correlate with infarct size and stroke
severity [20,22,23]. In this study, the limited sample size,
heterogeneity in infarct location and time after stroke
onset may in part account for our inability to verify this
presently.
A difference in the median ages between stroke dogs and
control dogs in the present study, although not statisti-
cally significant, should be taken into consideration as a
possible confounder as IL-6 has been reported to
increase with increasing age in humans as well as in the
ageing rat brain in some studies [26,27]. Yet, others report
no significant differences in IL-6 concentrations between
young individuals and carefully screened healthy elderly
individuals, and argue that a possible difference could be
explained by health-related conditions in the elderly [28].
In the present study, no concurrent disease or evidence
of systemic inflammation was identified in any of the
stroke dogs, supporting the increase in IL-6 to be a
consequence of the acute stroke condition.
We did not find any significant changes in the plasma or
CSF concentrations of IL-2, IL-8, IL-10 or TNF in dogs
with spontaneous stroke compared with the healthy
controls. Although some human clinical studies report a
parallel increase of serum TNF and IL-6 with ischaemic
stroke [21,29], several others failed to detect a change in
serum TNF in accordance with our results [20,24].
Investigations of TNF in CSF in humans broadly report
Fig. 1
MRI of pet dogs with acute ischaemic stroke (arrows). (a) MRI T2-weighted image, transverse section at the level of the thalamus in an 11-year-old
female Greyhound with a right-sided middle cerebral artery (MCA) infarct. (b) MRI T2-weighted image, transverse section at the level of the
cerebellum in a 10-year-old male Greyhound with a right-sided rostral cerebellar artery infarct (RCeA). (c) MRI T2-weighted image, transverse section
at the level of the thalamus in a 13-year-old male English Pointer with a right-sided thalamic infarct (Tha). (d) MRI T2-weighted image, transverse
section at the level of the cerebellum in a 6.5-year-old male Cavalier King Charles Spaniel with a cerebellar midline infarct (RCeA).
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elevated TNF concentrations within 24 h of stroke
depending on the severity and the location of the infarct
[23,29]. Experimental studies of temporal profiles of
TNF mRNA in rodents also show a general peak of
expression within 10–18 h of stroke onset [3,25]. In our
study, samples were collected within 24 h in only one
case, which could explain why we did not identify ele-
vated TNF concentrations in our stroke dogs.
We also found no correlation between IL-6 in plasma and
CSF despite the significant increase in both, which may
seem counterintuitive. The limited sample size was a
general weakness of the study, which may also account
for this. Recruitment of eligible patients turned out to be
a major challenge for the completion of the study, despite
including multiple animal hospitals. The strict inclusion
criterion of acute stroke (<72 h) with MRI verification is a
clear hurdle to the enrolment of dogs as only a few
veterinary hospitals have direct access to MRI.
Conclusion
Community-dwelling domestic dogs may have a place in
stroke research as a supplement to existing experimental
animal models. Although the ‘spontaneous stroke dog
model’ faces several challenges, in particular with respect
to the heterogeneity in animals (e.g. age, breed, stroke
location, risk factors), which can be controlled in
traditional animal models, this may, however, present a
setting that resembles the very heterogeneous circum-
stances of humans. Striking similarities to human
ischaemic stroke have reported previously been with
respect to symptomatology and infarct topography [14,15].
In addition, the present study showed that IL-6 con-
centrations increased in the CSF and plasma of dogs with
acute ischaemic stroke, which also corresponds well with
the findings in humans, supporting the translational
potential of spontaneous canine ischaemic stroke. Our
results support the dog with spontaneous ischaemic
stroke as an alternative clinical and noninvasive model for
studies of early infarct-related pathophysiology. Because
of the limited number of dogs investigated, we recom-
mend that our results be further explored in a larger
scale study.
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